Stephens & Co. Maintains Equal-Weight on Medifast, Lowers Price Target to $12
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Stephens & Co. analyst Jim Salera maintains Medifast (NYSE:MED) with a Equal-Weight and lowers the price target from $15 to $12.
Stephens & Co. analyst Jim Salera maintains Medifast (NYSE:MED) with a Equal-Weight and lowers the price target from $15 to $12.